title: Myeloid blast crisis evolving during imatinib treatment of an FIP1L1-PDGFR alpha-positive chronic myeloproliferative disease with prominent eosinophilia.
authors.forename: N
authors.initials: N
authors.lastname: von Bubnoff
authors.forename: M
authors.initials: M
authors.lastname: Sandherr
authors.forename: G
authors.initials: G
authors.lastname: Schlimok
authors.forename: R
authors.initials: R
authors.lastname: Andreesen
authors.forename: C
authors.initials: C
authors.lastname: Peschel
authors.forename: J
authors.initials: J
authors.lastname: Duyster
mesh_terms: D000368:Aged; D001752:Blast Crisis / Q000097:blood; D002908:Chronic Disease; D004802:Eosinophilia / Q000097:blood / Q000150:complications* / Q000473:pathology; D006801:Humans; D007958:Leukocyte Count; D008297:Male; D009196:Myeloproliferative Disorders / Q000097:blood / Q000150:complications* / Q000473:pathology; D015514:Oncogene Proteins, Fusion / Q000235:genetics; D010976:Platelet Count; D020796:Receptor, Platelet-Derived Growth Factor alpha / Q000235:genetics*; D039221:mRNA Cleavage and Polyadenylation Factors / Q000235:genetics*
chemical_list: D015514:Oncogene Proteins, Fusion; D039221:mRNA Cleavage and Polyadenylation Factors; C479819:FIP1L1-PDGFRA fusion protein, human; D020796:Receptor, Platelet-Derived Growth Factor alpha